The impact of radiation-related lymphocyte recovery on the prognosis of locally advanced esophageal squamous cell carcinoma patients: a retrospective analysis

被引:0
作者
Ji, Hongshan [1 ]
Zhang, Ping [1 ]
Zhen, Chanjun [1 ]
Fu, Liyuan [1 ]
Lv, Dongjie [1 ]
Bai, Wenwen [1 ]
Zhang, Rui [1 ]
Li, Jing [1 ]
Gao, Hang [1 ]
Wang, Yajing [1 ]
An, Qiuying [1 ]
Su, Yuhao [1 ]
Si, Hanyu [1 ]
Qiao, Xueying [1 ]
Zhou, Zhiguo [1 ]
机构
[1] Hebei Med Univ, Dept Radiat Oncol, Hosp 4, Shijiazhuang, Peoples R China
关键词
Esophageal cancer; Radiotherapy; Lymphocyte recovery; Prognosis; TREATMENT-RELATED LYMPHOPENIA; INTERLEUKIN-7; SURVIVAL;
D O I
10.1186/s13014-025-02587-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe impact of radiation-related lymphocyte recovery on prognosis in locally advanced esophageal squamous cell carcinoma (LA-ESCC) remains unclear. MethodsPatients with stage II-IVa ESCC who received definitive RT were screened. Collect absolute lymphocyte counts (ALCs) before, during, and after RT. The recovery status of lymphocytes was observed at one-month post-RT (P1) and three months post-RT (P3). Patients with relatively lower lymphocyte recovery levels at P1 were divided into Group a and those with higher levels were divided into Group b. Patients with relatively lower lymphocyte recovery levels at P3 were divided into Group A and those higher were divided into Group B. Kaplan-Merier's analysis and Cox analysis were conducted to compare survival outcomes. Binary logistic regression analyses was employed to ascertain factors associated with lymphocyte recovery. Results116 patients were enrolled. During RT, ALCs reached the bottom 5 weeks after RT started and 70.7% of patients experienced G3 lymphopenia. The median OS for Group a and Group b were 38.1 months and 14.4 months, p = 0.097. The median PFS for Group a and Group b were 14.2 months and 10.0 months, p = 0.037. Whereas, the median OS for Group A and Group B was 14.5 months and 22.2 months, p = 0.019. The median PFS for Group A and Group B were 8.4 months and 12.4 months, p = 0.021. Cox multivariable analysis revealed that higher lymphocyte recovery level at P3 was significantly associated with superior OS (p = 0.040, HR0.636) and PFS (p = 0.028, HR0.627). The logistic analysis identified a positive association between G4 lymphopenia during RT (p = 0.012, OR 7.742) and PTV dose < 60 Gy (p = 0.014, OR 2.655) with lymphocyte recovery. ConclusionsThe prognostic value of lymphocyte recovery status at P3 appears to be greater than that of lymphocyte recovery status at P1 for locally advanced ESCC patients. Radiation-related lymphocyte recovery might serve as a valuable prognostic factor in LA-ESCC.
引用
收藏
页数:8
相关论文
共 17 条
[1]   Effect of Interleukin-7 on Radiation-Induced Lymphopenia and Its Antitumor Effects in a Mouse Model [J].
Byun, Hwa Kyung ;
Kim, Kyoung-Jin ;
Han, Su Chul ;
Seong, Jinsil .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 109 (05) :1559-1569
[2]   Long-Acting Recombinant Human Interleukin-7, NT-17, Increases Cytotoxic CD8 T Cells and Enhances Survival in Mouse Glioma Models [J].
Campian, Jian L. ;
Ghosh, Subhajit ;
Kapoor, Vaishali ;
Yan, Ran ;
Thotala, Sukrutha ;
Jash, Arijita ;
Hu, Tong ;
Mahadevan, Anita ;
Rifai, Kasem ;
Page, Logan ;
Lee, Byung Ha ;
Ferrando-Martinez, Sara ;
Wolfarth, Alexandra A. ;
Yang, Se Hwan ;
Hallahan, Dennis ;
Chheda, Milan G. ;
Thotala, Dinesh .
CLINICAL CANCER RESEARCH, 2022, 28 (06) :1229-1239
[3]   Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy [J].
Cheng, Xingyuan ;
Chen, Baoqing ;
Wang, Sifen ;
Zhang, Jun ;
Zhu, Jinhan ;
Liu, Mengzhong ;
Liu, Shiliang ;
Xi, Mian .
ONCOLOGIST, 2023, :E606-E616
[4]   Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy [J].
Cho, Yeona ;
Kim, Yejin ;
Chamseddine, Ibrahim ;
Lee, Won Hee ;
Kim, Hye Ryun ;
Lee, Ik Jae ;
Hong, Min Hee ;
Cho, Byung Chul ;
Lee, Chang Geol ;
Cho, Seungryong ;
Kim, Jin Sung ;
Yoon, Hong In ;
Grassberger, Clemens .
RADIOTHERAPY AND ONCOLOGY, 2022, 168 :1-7
[5]   Chemoradiotherapy of locally advanced esophageal cancer - Long-term follow-up of a prospective randomized trial (RTOG 85-01) [J].
Cooper, JS ;
Guo, MD ;
Herskovic, A ;
Macdonald, JS ;
Martenson, JA ;
Al-Sarraf, M ;
Byhardt, R ;
Russell, AH ;
Beitler, JJ ;
Spencer, S ;
Asbell, SO ;
Graham, MV ;
Leichman, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17) :1623-1627
[6]   Severe Radiation-Induced Lymphopenia Affects the Outcomes of Esophageal Cancer: A Comprehensive Systematic Review and Meta-Analysis [J].
Dai, Dongjun ;
Tian, Qiaoying ;
Yu, Genhua ;
Shui, Yongjie ;
Jiang, Hao ;
Wei, Qichun .
CANCERS, 2022, 14 (12)
[7]   The Influence of Severe Radiation-Induced Lymphopenia on Overall Survival in Solid Tumors: A Systematic Review and Meta-Analysis [J].
Damen, Pim J. J. ;
Kroese, Tiuri E. ;
van Hillegersberg, Richard ;
Schuit, Ewoud ;
Peters, Max ;
Verhoeff, Joost J. C. ;
Lin, Steven H. ;
van Rossum, Peter S. N. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (04) :936-948
[8]   The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy [J].
Deng, Wei ;
Xu, Cai ;
Liu, Amy ;
van Rossum, Peter S. N. ;
Deng, Weiye ;
Liao, Zhongxing ;
Koong, Albert C. ;
Mohan, Radhe ;
Lin, Steven H. .
RADIOTHERAPY AND ONCOLOGY, 2019, 133 :9-15
[9]   Amifostine enhances recovery and expansion of peripheral FAS/CD95+T- and NK-cell subpopulations during radiotherapy of patients with head-neck cancer [J].
Koukourakis, George V. ;
Baksevanis, Constantinos N. ;
Zambatis, Haralambos ;
Gritzapis, Angelos ;
Maltezos, Efstratios ;
Simopoulos, Costantinos ;
Koukourakis, Michael I. .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2009, 85 (01) :96-104
[10]   Significance of lymphocyte recovery from treatment-related lymphopenia in locally advanced pancreatic cancer [J].
Lee, Byung Min ;
Byun, Hwa Kyung ;
Seong, Jinsil .
RADIOTHERAPY AND ONCOLOGY, 2020, 151 :82-87